Tango Therapeutics to Participate in 44th Annual J.P. Morgan Healthcare Conference

Core Viewpoint - Tango Therapeutics, Inc. is set to present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026, highlighting its focus on precision medicine for cancer treatment [1]. Company Overview - Tango Therapeutics is a clinical-stage biotechnology company focused on discovering novel drug targets and developing precision medicine for cancer treatment [3]. - The company employs the genetic principle of synthetic lethality to identify and create therapies targeting critical cancer-related elements [3]. Event Details - Barbara Weber, M.D., the President and CEO of Tango Therapeutics, will deliver the corporate presentation at 9:45am PST/12:45pm EST [1]. - A live webcast of the presentation will be available on the company's website, with a replay archived for 90 days post-event [2].